| International consensus guidance statement on the management and treatment of IgG4‐related disease A Khosroshahi, ZS Wallace, JL Crowe, T Akamizu, A Azumi, ... Arthritis & rheumatology 67 (7), 1688-1699, 2015 | 1083 | 2015 |
| Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study G Cavalli, G De Luca, C Campochiaro, E Della-Torre, M Ripa, D Canetti, ... The Lancet Rheumatology 2 (6), e325-e331, 2020 | 1050 | 2020 |
| The 2019 American College of Rheumatology/European league against rheumatism classification criteria for IgG4‐related disease ZS Wallace, RP Naden, S Chari, H Choi, E Della‐Torre, JF Dicaire, ... Arthritis & Rheumatology 72 (1), 7-19, 2020 | 821 | 2020 |
| Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations ZS Wallace, H Mattoo, M Carruthers, VS Mahajan, E Della Torre, H Lee, ... Annals of the rheumatic diseases 74 (1), 190-195, 2015 | 507 | 2015 |
| Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study C Campochiaro, E Della-Torre, G Cavalli, G De Luca, M Ripa, N Boffini, ... European journal of internal medicine 76, 43-49, 2020 | 448 | 2020 |
| De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease H Mattoo, VS Mahajan, E Della-Torre, Y Sekigami, M Carruthers, ... Journal of allergy and clinical immunology 134 (3), 679-687, 2014 | 394 | 2014 |
| Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease H Mattoo, VS Mahajan, T Maehara, V Deshpande, E Della-Torre, ... Journal of Allergy and Clinical Immunology 138 (3), 825-838, 2016 | 368 | 2016 |
| Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors M Ripa, L Galli, A Poli, C Oltolini, V Spagnuolo, A Mastrangelo, C Muccini, ... Clinical Microbiology and Infection 27 (3), 451-457, 2021 | 351 | 2021 |
| Prevalence of atopy, eosinophilia, and IgE elevation in IgG4‐related disease E Della Torre, H Mattoo, VS Mahajan, M Carruthers, S Pillai, JH Stone Allergy 69 (2), 269-272, 2014 | 277 | 2014 |
| Immunology of IgG4-related disease E Della-Torre, M Lanzillotta, C Doglioni Clinical & Experimental Immunology 181 (2), 191-206, 2015 | 274 | 2015 |
| IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment LX Lu, E Della-Torre, JH Stone, SW Clark JAMA neurology 71 (6), 785-793, 2014 | 264 | 2014 |
| Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study E Della-Torre, C Campochiaro, G Cavalli, G De Luca, A Napolitano, ... Annals of the rheumatic diseases 79 (10), 1277-1285, 2020 | 256 | 2020 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 255 | 2021 |
| Advances in the diagnosis and management of IgG4 related disease M Lanzillotta, G Mancuso, E Della-Torre Bmj 369, 2020 | 242 | 2020 |
| GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study G De Luca, G Cavalli, C Campochiaro, E Della-Torre, P Angelillo, ... The Lancet Rheumatology 2 (8), e465-e473, 2020 | 226 | 2020 |
| Causes of food-induced anaphylaxis in Italian adults: a multi-centre study R Asero, L Antonicelli, A Arena, L Bommarito, B Caruso, G Colombo, ... International archives of allergy and immunology 150 (3), 271-277, 2009 | 174 | 2009 |
| Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study G Cavalli, A Larcher, A Tomelleri, C Campochiaro, E Della-Torre, ... The Lancet Rheumatology 3 (4), e253-e261, 2021 | 168 | 2021 |
| EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi‐centre study R Asero, L Antonicelli, A Arena, L Bommarito, B Caruso, M Crivellaro, ... Clinical & Experimental Allergy 39 (4), 547-555, 2009 | 164 | 2009 |
| Identification of galectin-3 as an autoantigen in patients with IgG4-related disease CA Perugino, SB AlSalem, H Mattoo, E Della-Torre, V Mahajan, ... Journal of Allergy and Clinical Immunology 143 (2), 736-745. e6, 2019 | 161 | 2019 |
| IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients C Campochiaro, GA Ramirez, EP Bozzolo, M Lanzillotta, A Berti, ... Scandinavian journal of rheumatology 45 (2), 135-145, 2016 | 160 | 2016 |
